Acorda Therapeutics Inc EBITDA margin
Mi az Acorda Therapeutics Inc EBITDA margin?
A EBITDA margin az Acorda Therapeutics Inc - -3.45%
Mi a EBITDA margin meghatározása?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin a Health Care szektor a NASDAQ-on cégekben a Acorda Therapeutics Inc -hoz képest
Mit csinál Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
ebitda margin -hoz hasonló cégek Acorda Therapeutics Inc
- Gold By Gold SA nak EBITDA margin -3.47% van
- Dominate nak EBITDA margin -3.47% van
- China Natural Resources Inc nak EBITDA margin -3.46% van
- Fe nak EBITDA margin -3.46% van
- I.T nak EBITDA margin -3.46% van
- Hermitage Offshore Services nak EBITDA margin -3.46% van
- Acorda Therapeutics Inc nak EBITDA margin -3.45% van
- Zinc Media plc nak EBITDA margin -3.43% van
- China Shun Ke Long nak EBITDA margin -3.43% van
- Umang Dairies nak EBITDA margin -3.42% van
- China Jo-Jo Drugstores Inc nak EBITDA margin -3.42% van
- GE T&D India nak EBITDA margin -3.40% van
- Kirkland`s Inc nak EBITDA margin -3.40% van